Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Vitamin K Market

Vitamin K Market Share

Report ID: GMI1481
Published Date: May 2023
Report Format: PDF

Download Free Sample

Vitamin K Market Share

Some of the leading vitamin K market contenders are

NattoPharma ASA
BASF SE
Country Life,LLC (Kikkoman Corporation)
Pfizer Inc.
Amphastar Pharmaceuticals Inc.
DSM
Kappa Bioscience
Livealth Biopharma Pvt. Ltd.
NOW Foods
Solgar Inc.

These firms are working on product approvals, acquisitions and several other strategies to sustain the rising competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for vitamin K reached USD 839 million in 2022 and is estimated to witness 8.7% CAGR from 2023-2032 due to the growing burden of chronic diseases, such as diabetes, arthritis, and cardiovascular diseases worldwide.

Vitamin K1 segment will observe 8.2% CAGR from 2023-2032 owing to the growing popularity of diet supplements.

North America vitamin K market will reach over USD 858 million by 2032 owing to the surging prevalence of chronic diseases and coagulation disorders.

NattoPharma ASA, BASF SE, Country Life, LLC (Kikkoman Corporation), Pfizer Inc., Amphastar Pharmaceuticals Inc., DSM, Kappa Bioscience, Livealth Biopharma Pvt. Ltd., NOW Foods, and Solgar Inc. are some of the renowned vitamin K industry players.